# Jize Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jize-biotechnology

- Industry: Biotechnology
- Headquarters: Chongqing, China
- Latest round: Series B (Mar 11, 2026)
- Investors on record: 4

## About

Based in Chongqing, China and founded in 2019, Chongqing Jize Biotechnology Co., Ltd., trading as Jize Biotechnology, is a pharmaceutical manufacturer with pharmaceutical businesses. In March 2026, Jize Biotechnology raised a series B funding from CDH Investments, China International Capital Corporation, and Moutai(Guizhou) Investment Management.
The company’s business includes pharmaceutical production, wholesale, import and export, retail, food sales, food production, and production of foods for special medical purposes. Through biotechnology, the company develops products for the health and wellness industry and has successfully scaled up its processes for industrialization.
The company’s revenue is generated by providing artificial bear bile powder and other pharmaceutical products.

## Funding rounds

- Series B, Mar 11, 2026 — CDH Investments, China International Capital Corporation, Moutai(Guizhou) Investment Management
- Series A, Dec 4, 2025 — Guoli Minsheng Capital, Moutai(Guizhou) Investment Management

## Investors

- Guoli Minsheng Capital (https://capitalatlas.ai/funds/guoli-minsheng-capital) — Series A
- Moutai(Guizhou) Investment Management (https://capitalatlas.ai/funds/moutai-guizhou-investment-management) — Series A, Series B
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B